These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9598116)

  • 41. Treatment of collagen diseases with cytostatics.
    Lorenzen I; Videbaek A
    Lancet; 1965 Sep; 2(7412):558-61. PubMed ID: 4158189
    [No Abstract]   [Full Text] [Related]  

  • 42. Azathioprine and cyclophosphamide in the treatment of rheumatoid arthritis.
    Gaffney K; Scott DG
    Br J Rheumatol; 1998 Aug; 37(8):824-36. PubMed ID: 9734673
    [No Abstract]   [Full Text] [Related]  

  • 43. [Azathioprine in rheumatology].
    Mathies H
    Fortschr Med; 1979 Dec; 97(48):2215-7. PubMed ID: 43824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever.
    Oliveira AC; Mota LM; Santos-Neto LL; Simões M; Martins-Filho OA; Tauil PL
    Arthritis Rheumatol; 2015 Feb; 67(2):582-3. PubMed ID: 25418753
    [No Abstract]   [Full Text] [Related]  

  • 45. Rhupus syndrome.
    Min JK; Lee KA; Kim HR; Kim HY; Lee SH
    Korean J Intern Med; 2015 Jan; 30(1):131. PubMed ID: 25589849
    [No Abstract]   [Full Text] [Related]  

  • 46. [Morbidity and mortality in systemic rheumatoid diseases: how did they change?].
    Reinhold-Keller E; Zink A
    Z Rheumatol; 2011 Aug; 70(6):462-3. PubMed ID: 21863466
    [No Abstract]   [Full Text] [Related]  

  • 47. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F; Isenberg DA
    Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rheumatic Disease Autoantibodies in Autoimmune Liver Diseases.
    Utiyama SR; Zenatti KB; Nóbrega HA; Soares JZ; Skare TL; Matsubara C; Muzzilo DA; Nisihara RM
    Immunol Invest; 2016 Aug; 45(6):566-73. PubMed ID: 27409579
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymphocyte characteristics in rheumatic patients and the effect of azathioprine therapy.
    Yy DT; Clements PJ; Peter JB; Levy J; Paulus HE; Barnett EV
    Arthritis Rheum; 1974; 17(1):37-45. PubMed ID: 4589815
    [No Abstract]   [Full Text] [Related]  

  • 50. [Rheumatoid arthritis treated by administration of imuran and actinomycin-c].
    Moens C
    Arch Interam Rheumatol; 1965 Dec; 8(4):278-87. PubMed ID: 4160470
    [No Abstract]   [Full Text] [Related]  

  • 51. Aplastic anemia secondary to azathioprine in systemic lupus erythematosus: report of a case with normal thiopurine S-methyltransferase enzyme activity and review of the literature.
    Yeter KC; Afkhami M; Brynes RK; Quismorio FP
    Lupus; 2013 Dec; 22(14):1526-8. PubMed ID: 24029750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prerequisites and first results of the therapeutic use of azathioprine (imuran) in chronic progressive rheumatic arthritis and in so-called collagen diseases].
    Barnikol HU; Vorlaender KO
    Med Welt; 1967 Jan; 3():160-9. PubMed ID: 4383822
    [No Abstract]   [Full Text] [Related]  

  • 53. Recent advances in rheumatology: biological agents for the treatment of rheumatoid arthritis, the progression of psoriatic arthritis, autoantibodies in systemic lupus erythematosus.
    Finucane KA; Archer CB
    Clin Exp Dermatol; 2005 Mar; 30(2):201-4. PubMed ID: 15725261
    [No Abstract]   [Full Text] [Related]  

  • 54. Altered immunoglobulin metabolism in systemic lupus erythematosus and heumatoid arthritis.
    Levy J; Barnett EV; MacDonald NS; Klinenberg JR
    J Clin Invest; 1970 Apr; 49(4):708-15. PubMed ID: 5309797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacoeconomic analysis of thiopurine methyltransferase polymorphism screening by polymerase chain reaction for treatment with azathioprine in Korea.
    Oh KT; Anis AH; Bae SC
    Rheumatology (Oxford); 2004 Feb; 43(2):156-63. PubMed ID: 12923290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Letter: Long-term side effects of azathioprine.
    Urowitz MB; Gordon DA; Smythe HA; Pruzanski W; Ogryzlo MA
    Arthritis Rheum; 1974; 17(6):1060-1. PubMed ID: 4215427
    [No Abstract]   [Full Text] [Related]  

  • 57. Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.
    Neighbour PA; Grayzel AI
    Clin Exp Immunol; 1981 Sep; 45(3):576-82. PubMed ID: 6175456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Menopause and Rheumatic Disease.
    Talsania M; Scofield RH
    Rheum Dis Clin North Am; 2017 May; 43(2):287-302. PubMed ID: 28390570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of CEP (chronic evolutive polyarthritis) by immunosuppressive substances. Clinical and immunological study].
    Moens C; Brocteur J
    J Belge Rhumatol Med Phys; 1966; 21(1):5-10. PubMed ID: 4161300
    [No Abstract]   [Full Text] [Related]  

  • 60. Preliminary results of azathioprine treatment in severe rheumatic disease.
    Swannell AJ; Coomes EN
    Ann Phys Med; 1969 Aug; 10(3):112-20. PubMed ID: 4314025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.